Skip to main content
Top
Published in: International Journal of Hematology 5/2011

01-11-2011 | Letter to the Editor

Motor disability in the setting of oral anticoagulant therapy

Authors: Laura Scaramucci, Andrea Tendas, Pasquale Niscola, Francesco Bondanini, Marco Giovannini, Massimiliano Palombi, Luca Cupelli, Fabio Efficace, Alessio Perrotti, Paolo de Fabritiis

Published in: International Journal of Hematology | Issue 5/2011

Login to get access

Excerpt

Oral anticoagulant therapy (OAT) is a widely applied measure for the prevention of thrombotic events in a broad range of diseases. OAT is chronically administered and, given its narrow therapeutic range, its management requires close monitoring of prothrombin time (PT) and the international normalized ratio (INR) to balance the risk of hemorrhage and thrombosis. Although PT/INR can be assessed by healthcare professionals or by patients themselves [1], individuals on OAT are usually followed at an outpatient center specializing in hematology. Patients on OAT are typically older individuals and may be affected by various diseases and comorbidities which may exhibit debilitating deteriorations in personal status, physical impairment, several forms of motor disability (MD), and limitations in performing activities of daily living (ADL), the latter eventually resulting in the loss of independence. Moreover, limitations in performing daily activities can compromise the patient’s quality of life (QoL) and increase the burden on caregivers. Therefore, the need of hospital visits may be problematic, given the complex burden of frailty and disability afflicting many patients on OAT, above all the elderly and those with multiple comorbidities. In this regard, hematologists and other medical specialists providing OAT will increasingly be faced with problems arising from functional decline and physical deterioration. Although these concerns are observed as common complaints in patients on OAT in daily clinical practice, information regarding its origins, frequency, and management is relatively scarce. To address this issue, we conducted a cross-sectional evaluation of the MD in a group of consecutive OAT patients. MD was assessed with the Barthel index (BI) [2], which has been used in our previous studies on physical status and motor impairment in hematological patients. As in these previous reports [3, 4], in the present study BI was used as the basic ADL ability scale, and was classified as mild (BI > 66%), moderate (BI 33–66%) and severe (BI < 33%). There were 122 patients (73 male); median age was 71 (27–91) years. Disability was present in 37/122 (30%) patients; of the 37 disabled patients, motor impairment was mild in 33 (90%), moderate in 3 (7%) and severe in 1 (3%) patients, respectively. Analysis of BI items (Fig. 1; Table 1) revealed that bladder function and complex activities are the most frequently impaired basic ADL in patients on OAT. Although preliminary and related to a limited series of patients, our data add to the scarce knowledge on disability in the management of OAT and may stimulate further research on this neglected issue. MD is a frequent feature and larger data analyses are likely to provide a better understanding of the disablement process, onset, causes, related risk factors and progression. Meanwhile, for physically impaired patients on chronic OAT, which are only one-third of the total but represent an important management burden if we consider the entire OAT population, we should develop facilitation strategies. In this view, home care management [5], including the at-home use of a portable PT monitor [1] in selected patients, may be suitable options, although these would require a team of trained healthcare professionals and adequate resources. Therefore, a targeted rehabilitative approach to prevent and treat disability may lead to positive effects on both patient’s QoL and caregiver workload.
Table 1
Mean values of each item expressed as percentage reduction compared with normal
Item
%
Bladder
−14
Stairs
−11
Bathing
−8
Dressing
−7
Mobility
−5
Toilet
−4
Bowels
−3
Feeding
−3
Grooming
−2
Transfer
−2
Literature
1.
go back to reference Cosmi B, Palareti G, Carpanedo M, Pengo V, Biasiolo A, Rampazzo P, Morstabilini G, Testa S. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). Haematologica. 2000;85(8):826–31.PubMed Cosmi B, Palareti G, Carpanedo M, Pengo V, Biasiolo A, Rampazzo P, Morstabilini G, Testa S. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). Haematologica. 2000;85(8):826–31.PubMed
2.
go back to reference Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.PubMed Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.PubMed
3.
go back to reference Tendas A, Niscola P, Cinque R, Cupelli L, Giovannini M, Ales M, Dentamaro T, Scaramucci L, de Fabritiis P. Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leukoc Res. 2010;34(2):e66.PubMedCrossRef Tendas A, Niscola P, Cinque R, Cupelli L, Giovannini M, Ales M, Dentamaro T, Scaramucci L, de Fabritiis P. Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leukoc Res. 2010;34(2):e66.PubMedCrossRef
4.
go back to reference Tendas A, Niscola P, Ales M, Baraldi L, Boschetto C, Caiazza E, Cupelli L, Giovannini M, Scaramucci L, Brunetti G, Cartoni C, Mandelli F, de Fabritiis P. Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Support Care Cancer. 2009;17(12):1559–60.PubMedCrossRef Tendas A, Niscola P, Ales M, Baraldi L, Boschetto C, Caiazza E, Cupelli L, Giovannini M, Scaramucci L, Brunetti G, Cartoni C, Mandelli F, de Fabritiis P. Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Support Care Cancer. 2009;17(12):1559–60.PubMedCrossRef
5.
go back to reference Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program. Indian J Palliat Care. 2011;17(1):54–6.PubMedCrossRef Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program. Indian J Palliat Care. 2011;17(1):54–6.PubMedCrossRef
Metadata
Title
Motor disability in the setting of oral anticoagulant therapy
Authors
Laura Scaramucci
Andrea Tendas
Pasquale Niscola
Francesco Bondanini
Marco Giovannini
Massimiliano Palombi
Luca Cupelli
Fabio Efficace
Alessio Perrotti
Paolo de Fabritiis
Publication date
01-11-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0945-1

Other articles of this Issue 5/2011

International Journal of Hematology 5/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine